Jiangxi Rimag Group Co., Ltd. (RIMAG GROUP) Aktie

Jiangxi Rimag Group Co., Ltd., together with its subsidiaries, invests in and operates medical imaging centers in Mainland China, Hong Kong, Macau, and internationally. It operates through Imaging Center Services, Imaging Solution Services, and Digital-Intelligent Services segments. The company offers imaging examination and diagnostic imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy, and other related procedures to hospitals and other medical institutions, health management companies, individual patients, and other healthcare customers; medical imaging operational management services; imaging equipment and software solutions; imaging capability improvement services; imaging empowerment solutions, such as equipment selection and configuration, quality control, remote consultation, medical staff training, clinical imaging capability analysis, and repair services. It also provides Rimag Cloud services, including cloud storage and cloud film modules, remote diagnosis and consultation for complex cases, remote hosting services, imaging AI integration platform, refined operation management modules, cloud radiology information system (RIS) modules, and quality control modules; data processing and analysis solutions; and remote and AI diagnosis services. In addition, the company engages in the operation and management of a medical imaging cloud platform that provides diversified imaging services; operation of a research and development center; technical support; sale of medical devices and consumables; clinic services; maintenance and installation of medical equipment; technology development of medical imaging cloud platforms; and medical imaging industry chain services. Jiangxi Rimag Group Co., Ltd. was incorporated in 2014 and is headquartered in Beijing, China.